Cohort studies

Latest Articles

Article
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.

Neurology September 12, 2019
Editorial
Do good things come to those who wait?Dosing interval of natalizumab in MS
David B. Clifford, Kenneth L. Tyler

Neurology September 12, 2019
Article
Long-term health-related quality of life in 262 patients with brain arteriovenous malformation
Anni Pohjola, Elias Oulasvirta, Risto P. Roine, et al.

Neurology September 11, 2019
Article
Excessive daytime sleepiness and topographic expansion of Lewy pathology
Robert D. Abbott, G. Webster Ross, John E. Duda, et al.

Neurology August 30, 2019